|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Reig M, Forner A, Rimola J, Ferrer-Fàbrega
J, Burrel M, Garcia-Criado Á, Kelley RK, Galle PR, Mazzaferro V,
Salem R, et al: BCLC strategy for prognosis prediction and
treatment recommendation: The 2022 update. J Hepatol. 76:681–693.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kimura T, Fujiwara T, Kameoka T, Adachi Y
and Kariya S: The current role of stereotactic body radiation
therapy (SBRT) in hepatocellular carcinoma (HCC). Cancers (Basel).
14:43832022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
The Japan Society of Hepatology (ed), .
Clinical Practice Guidelines for Hepatocellular Carcinoma 2025. 6th
Edition. Kanehara & Co., Ltd.; Tokyo, Japan: pp. 902025, (In
Japanese).
|
|
5
|
Younossi ZM, Golabi P, Paik JM, Henry A,
Van Dongen C and Henry L: The global epidemiology of nonalcoholic
fatty liver disease (NAFLD) and nonalcoholic steatohepatitis
(NASH): A systematic review. Hepatology. 77:1335–1347. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Toh MR, Wong EYT, Wong SH, Ng AWT, Loo LH,
Chow PK and Ngeow J: Global epidemiology and genetics of
hepatocellular carcinoma. Gastroenterology. 164:766–782. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pfister D, Núñez NG, Pinyol R, Govaere O,
Pinter M, Szydlowska M, Gupta R, Qiu M, Deczkowska A, Weiner A, et
al: NASH limits anti-tumour surveillance in immunotherapy-treated
HCC. Nature. 592:450–456. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shimose S, Hiraoka A, Casadei-Gardini A,
Tsutsumi T, Nakano D, Iwamoto H, Tada F, Rimini M, Tanaka M,
Torimura T, et al: The beneficial impact of metabolic
dysfunction-associated fatty liver disease on lenvatinib treatment
in patients with non-viral hepatocellular carcinoma. Hepatol Res.
53:104–115. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bian X, Liu R, Meng Y, Xing D, Xu D and Lu
Z: Lipid metabolism and cancer. J Exp Med. 218:e202016062021.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martin-Perez M, Urdiroz-Urricelqui U,
Bigas C and Benitah SA: The role of lipids in cancer progression
and metastasis. Cell Metab. 34:1675–1699. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li J, Wang T, Liu P, Yang F, Wang X, Zheng
W and Sun W: Hesperetin ameliorates hepatic oxidative stress and
inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic
acid-induced HepG2 cells and a rat model of high-fat diet-induced
NAFLD. Food Funct. 12:3898–3918. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang Y, Chen J, Gao Q, Shan X, Wang J and
Lv Z: Study on the attenuated effect of Ginkgolide B on ferroptosis
in high fat diet induced nonalcoholic fatty liver disease.
Toxicology. 445:1525992020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang J, Zhang SD, Wang P, Guo N, Wang W,
Yao LP, Yang Q, Efferth T, Jiao J and Fu YJ: Pinolenic acid
ameliorates oleic acid-induced lipogenesis and oxidative stress via
AMPK/SIRT1 signaling pathway in HepG2 cells. Eur J Pharmacol.
861:1726182019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Muscaritoli M, Arends J, Bachmann P,
Baracos V, Barthelemy N, Bertz H, Bozzetti F, Hütterer E, Isenring
E, Kaasa S, et al: ESPEN practical guideline: Clinical nutrition in
cancer. Clin Nutr. 40:2898–2913. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Allen BG, Bhatia SK, Buatti JM, Brandt KE,
Lindholm KE, Button AM, Szweda LI, Smith BJ, Spitz DR and Fath MA:
Ketogenic diets enhance oxidative stress and radio-chemo-therapy
responses in lung cancer xenografts. Clin Cancer Res. 19:3905–3913.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zahra A, Fath MA, Opat E, Mapuskar KA,
Bhatia SK, Ma DC, Rodman SN III, Snyders TP, Chenard CA,
Eichenberger-Gilmore JM, et al: Consuming a ketogenic diet while
receiving radiation and chemotherapy for locally advanced lung
cancer and pancreatic cancer: The University of Iowa experience of
two phase 1 clinical trials. Radiat Res. 187:743–754. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Z, Tian R, She Z, Cai J and Li H:
Role of oxidative stress in the pathogenesis of nonalcoholic fatty
liver disease. Free Radic Biol Med. 152:116–141. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ursini F and Maiorino M: Lipid
peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic
Biol Med. 152:175–185. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Verheij M: Clinical biomarkers and imaging
for radiotherapy-induced cell death. Cancer Metastasis Rev.
27:471–480. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matt S and Hofmann TG: The DNA
damage-induced cell death response: A roadmap to kill cancer cells.
Cell Mol Life Sci. 73:2829–2850. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Listenberger LL, Han X, Lewis SE, Cases S,
Farese RV Jr, Ory DS and Schaffer JE: Triglyceride accumulation
protects against fatty acid-induced lipotoxicity. Proc Natl Acad
Sci USA. 100:3077–3082. 2023. View Article : Google Scholar
|
|
23
|
Ricchi M, Odoardi MR, Carulli L, Anzivino
C, Ballestri S, Pinetti A, Fantoni LI, Marra F, Bertolotti M, Banni
S, et al: Differential effect of oleic and palmitic acid on lipid
accumulation and apoptosis in cultured hepatocytes. J Gastroenterol
Hepatol. 24:830–840. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Chen C, Chen J, Sang T, Peng H,
Lin X, Zhao Q, Chen S, Eling T and Wang X: Overexpression of
NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative
stress-mediated dsDNA release and AIM2 inflammasome activation.
Redox Biol. 52:1023222022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sgonc R and Gruber J: Apoptosis detection:
An overview. Exp Gerontol. 33:525–533. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hashimoto K, Oda Y, Nakagawa K, Ikeda T,
Ohtani K and Akagi M: LOX-1 deficient mice show resistance to
zymosan-induced arthritis. Eur J Histochem. 62:28472018.PubMed/NCBI
|
|
27
|
Balachander GJ, Subramanian S and Ilango
K: Rosmarinic acid attenuates hepatic steatosis by modulating ER
stress and autophagy in oleic acid-induced HepG2 cells. RSC Adv.
8:26656–26663. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li JY, Ren C, Wang LX, Yao RQ, Dong N, Wu
Y, Tian YP and Yao YM: Sestrin2 protects dendrite cells against
ferroptosis induced by sepsis. Cell Death Dis. 12:8342021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ye LF, Chaudhary KR, Zandkarimi F, Harken
AD, Kinslow CJ, Upadhyayula PS, Dovas A, Higgins DM, Tan H, Zhang
Y, et al: Radiation-induced lipid peroxidation triggers ferroptosis
and synergizes with ferroptosis inducers. ACS Chem Biol.
15:469–484. 2020. View Article : Google Scholar : PubMed/NCBI
|
